Tirzepatide with Glycine

Personalized Weight Loss
Next-Level Weight Loss and Metabolic Support in One Powerful Injection

Tirzepatide with Glycine is an advanced compounded formulation that combines the powerful dual-action GLP-1/GIP medication tirzepatide with glycine, a conditionally essential amino acid that supports cellular repair, detoxification, and anti-inflammatory balance. Together, they offer a cutting-edge, physician-supervised solution for patients seeking meaningful, sustainable weight loss with added support for metabolic recovery and overall vitality.

Administered via once-weekly subcutaneous injection, this combination is ideal for patients dealing with obesity, insulin resistance, or metabolic syndrome—and those looking to protect their long-term health during rapid weight loss.

Understanding Tirzepatide with Glycine

Tirzepatide works by mimicking two gut hormones—GLP-1 and GIP—which:

  • Suppress appetite

  • Slow gastric emptying

  • Improve insulin sensitivity

  • Lower blood glucose levels

By adding glycine, this formulation supports:

  • Tissue repair and anti-inflammatory response

  • Detoxification and glutathione production

  • Improved sleep and cognitive clarity

This enhanced combination not only helps drive fat loss but also supports cellular health and recovery during the process—helping patients feel more resilient, energetic, and balanced.

Potential Benefits
  • Significant Weight Loss
    Clinical trials show tirzepatide helps patients lose 15–20% or more of their body weight with medical guidance.
  • Appetite Control & Craving Reduction
    Dual-hormone action helps regulate hunger and promote satiety between meals.
  • Improved Metabolic Markers
    Supports lower blood sugar, reduced insulin levels, and better lipid profiles.
  • Cellular Resilience & Recovery
    Glycine aids in detox, supports mitochondrial function, and enhances tissue repair.
  • Non-Stimulant Formula
    No jitters or crashes—just regulated appetite and consistent energy.
Key Ingredients
  • Tirzepatide (Compounded):
    A dual GLP-1 and GIP receptor agonist that enhances satiety, improves insulin function, and drives significant fat loss.
  • Glycine:
    A conditionally essential amino acid that supports detoxification, inflammation modulation, neurotransmitter function, and metabolic repair.

Formulated by a licensed compounding pharmacy. Doses are titrated based on patient tolerance and provider protocol.

Warnings & Information
  • Prescription Required
    Tirzepatide with Glycine is available only through a licensed healthcare provider.
  • Not for All Patients
    Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 syndrome.
  • Common Side Effects
    May include nausea, constipation, diarrhea, or injection site discomfort. Glycine may help reduce inflammation-related side effects.
  • Monitoring Required
    Regular follow-ups and lab work are recommended to track blood sugar, kidney function, and treatment tolerance.
  • Not Safe for Use During Pregnancy
    Discontinue use if pregnant or planning to become pregnant. Safety in breastfeeding has not been established.